Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$56.7K Sell
44,287
-179
-0.4% -$252 ﹤0.01% 959
2026
Q1
$66.3K Buy
44,466
+179
+0.4% +$272 ﹤0.01% 945
2025
Q4
$58.5K Hold
44,287
﹤0.01% 923
2025
Q3
$60.7K Sell
44,287
-6,218
-12% -$8.28K ﹤0.01% 859
2025
Q2
$71.2K Sell
50,505
-2,000
-4% -$2.83K ﹤0.01% 838
2025
Q1
$83.5K Hold
52,505
﹤0.01% 813
2024
Q4
$186K Buy
52,505
+2,000
+4% +$7.99K ﹤0.01% 809
2024
Q3
$107K Hold
50,505
﹤0.01% 785
2024
Q2
$214K Hold
50,505
﹤0.01% 764
2024
Q1
$167K Hold
50,505
﹤0.01% 802
2023
Q4
$107K Hold
50,505
﹤0.01% 798
2023
Q3
$107K Hold
50,505
﹤0.01% 784
2023
Q2
$162K Buy
+50,505
New +$144K ﹤0.01% 772

Other funds holding GERN

Pinnacle Associates's GERN Position: Q2 2026 in Review

Pinnacle Associates reduced its Geron (GERN) stake by 0.4% in Q2 2026, selling an estimated $252 and leaving 44,287 shares worth $56.7K. The position accounts for ﹤0.01% of the portfolio, ranked #959.

Pinnacle Associates first reported a position in GERN in Q2 2023 and has held it in 13 quarters since. The position peaked at $214K in Q2 2024. 259 funds tracked by Wall St. Rank hold GERN as of Q2 2026.

  • Pinnacle Associates held 44,287 shares of Geron worth $56.7K as of Q2 2026.
  • Pinnacle Associates sold 179 Geron shares in Q2 2026, an estimated $252.
  • Geron made up ﹤0.01% of Pinnacle Associates's portfolio in Q2 2026, its #959 holding.
  • Pinnacle Associates first reported a position in Geron in Q2 2023 and has held it in 13 quarters since.
  • Pinnacle Associates's Geron position peaked at $214K in Q2 2024.
  • 259 funds tracked by Wall St. Rank held Geron as of Q2 2026.

Based on Pinnacle Associates's 13F filing for Q2 2026, filed 3 Aug 2026.